目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3.3 REGIONS COVERED
1.4 YEARS CONSIDERED
1.5 UNITS CONSIDERED
1.5.1 CURRENCY/VALUE UNIT
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM UP APPROACH
2.2.2 TOP DOWN APPROACH
2.3 MARKET GROWTH FORECAST
2.4 DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 LIMITATIONS
2.7 RISK ASSESSMENT
2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 SUPPLY CHAIN ANALYSIS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 SINGLE-USE TECHNOLOGY
5.4.1.2 AUTOMATED CELL EXPANSION
5.4.2 COMPLIMENTARY TECHNOLOGIES
5.4.2.1 HIGH THROUGHPUT SCREENING
5.4.2.2 SINGLE CELL ANALYSIS
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 MICROFLUIDICS AND ORGAN-ON-A-CHIP
5.4.3.2 3D BIOPRINTING
5.5 TRADE DATA ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.6.1 RESEARCH AND PRODUCT DEVELOPMENT
5.6.2 RAW MATERIAL PROCUREMENT
5.6.3 MANUFACTURING
5.6.4 SHIPMENT
5.6.5 MARKETING AND SALES
5.6.6 POST SALES SERVICE
5.7 PRICING ANALYSIS
5.7.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.7.2 AVERAGE SELLING PRICE TREND, BY REGION
5.8 ECOSYSTEM ANALYSIS
5.8.1 CELL EXPANSION PRODUCT VENDORS
5.8.2 CELL EXPANSION END USERS
5.8.3 REGULATORY AUTHORITIES
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.10 PATENT ANALYSIS
5.10.1 PATENTS FILLED, BY DOCUMENT TYPE, 2014-2024
5.10.2 INNOVATION AND PATENT APPLICATIONS
5.10.3 TOP APPLICANTS
5.11 KEY CONFERENCES & EVENTS, 2024-2025
5.12 REGULATORY LANDSCAPE
5.12.1 REGULATORY SCENARIO
5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES & OTHER ORGANIZATIONS
5.13 PORTER’S FIVE FORCES ANALYSIS
5.13.1 THREAT OF NEW ENTRANTS
5.13.2 THREAT OF SUBSTITUTES
5.13.3 BARGAINING POWER OF SUPPLIERS
5.13.4 BARGAINING POWER OF BUYERS
5.13.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.14.2 BUYING CRITERIA FOR END USERS
5.15 INVESTMENT AND FUNDING SCENARIO

6 CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
6.1 INTRODUCTION
6.2 CONSUMABLES
6.2.1 MEDIA
6.2.1.1 SERUM-FREE MEDIA
6.2.1.2 CLASSICAL MEDIA & SALTS
6.2.1.3 STEM CELL CULTURE MEDIA
6.2.1.4 SPECIALITY MEDIA
6.2.1.5 CHEMICALLY DEFINED MEDIA
6.2.1.6 OTHER MEDIA
6.2.2 SERA
6.2.3 REAGENTS
6.2.4 VESSELS
6.2.4.1 ROLLER/ROUX BOTTLES
6.2.4.2 CELL FACTORY SYSTEMS/CELL STACKS
6.2.4.3 MULTIWELL PLATES
6.2.4.4 FLASKS
6.2.4.5 PETRI DISHES
6.2.4.6 CELL EXPANSION BAGS
6.2.5 OTHER CONSUMABLES
6.3 EQUIPMENT
6.3.1 AUTOMATED CELL EXPANSION SYSTEMS
6.3.2 BIOREACTORS, BY USAGE
6.3.1.1 CONVENTIONAL BIOREACTORS
6.3.1.2 SINGLE-USE BIOREACTORS
6.3.2 BIOREACTORS, BY TYPE
6.3.2.1 MICROCARRIER BIOREACTOR
6.3.2.2 SUSPENSION BASED INDEPENDENT BIOREACTOR
6.3.2.3 HOLLOW FIBER BIOREACTOR
6.3.2.4 OTHER BIOREACTORS
6.3.3 OTHER CELL EXPANSION EQUIPMENT
Note 1: The other media include bacterial, insect cell culture media, protein-free media, and serum-containing media.
Note 2: Other bioreactors type includes membrane bioreactor, stir tank bioreactor, and wave bioreactor.
Note 3: Other consumables include controllers, sensors, and connectors.
Note 4: Other cell expansion equipment include mixers, incubators, laminar air flow, and biosafety cabinets.

7 CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
7.1 INTRODUCTION
7.2 HUMAN CELLS
7.2.1 STEM CELLS
7.2.1.1 ADULT STEM CELLS
7.2.1.2 INDUCED PLURIPOTENT STEM CELLS
7.2.1.3 EMBRYONIC STEM CELLS
7.2.2 DIFFERENCIATED CELLS
7.3 ANIMAL CELLS
7.3.1 CHINESE HAMSTER OVARY CELLS (CHO)
7.3.2 MOUSE EMBRYONIC STEM CELLS (MESCS)
7.3.3 OTHER ANIMAL CELLS
7.4 OTHER CELL TYPES
Note 5: Other animal cells include mouse fibroblast, mouse lymphoblast, and rat neuronal cells.
Note 6: Other cell types include plant cells and microbial cells.

8 CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
8.1 INTRODUCTION
8.2 BIOPHARMACEUTICAL PRODUCTION
8.2.1 MONOCLONAL ANTIBODY PRODUCTION
8.2.2 VACCINE PRODUCTION
8.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION
8.3 DRUG SCREENING & DEVELOPMENT
8.4 TISSUE ENGINEERING AND REGENERATIVE MEDICINE
8.4.1 CELL AND GENE THERAPY
8.4.3 OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS
8.6 OTHER APPLICATIONS
Note 7: Other therapeutic proteins include anticoagulants, enzymes, blood factors, hormones, interferons, growth factors, interleukins (cytokines), engineered proteins, and thrombolytics.
Note 8: Other tissue-engineering and regenerative medicine include 3D scaffolds, in vitro grown organs, and biomaterials.
Note 9: Other applications include toxicology and clinical research.

9 CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
9.1 INTRODUCTION
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3 HOSPITALS AND DIAGNOSTIC LABORATORIES
9.4 RESEARCH & ACADEMIC INSTITUTES
9.5 OTHER END USERS
Note 10: Other end users include cell banks, CROs, and CMOs.

10 CELL EXPANSION MARKET, BY REGION, 2022-2029 (USD MILLION)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.2.3 RECESSION IMPACT
10.3 EUROPE
10.3.1 GERMANY
10.3.2 UK
10.3.3 FRANCE
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE
10.3.7 RECESSION IMPACT
10.4 ASIA PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 SOUTH KOREA
10.4.5 AUSTRALIA
10.4.6 REST OF ASIA PACIFIC
10.4.7 RECESSION IMPACT
10.5 LATIN AMERICA
10.5.1 BRAZIL
10.5.2 MEXICO
10.5.3 REST OF LATIN AMERICA
10.5.4 RECESSION IMPACT
10.6 MIDDLE EAST
10.6.1 GCC
10.6.1.1 UNITED ARAB EMIRATES (UAE)
10.6.1.2 SAUDI ARABIA (KSA)
10.6.1.3 REST OF GCC
10.6.2 REST OF MIDDLE EAST
10.6.3 RECESSION IMPACT
10.7 AFRICA
10.7.1 RECESSION IMPACT

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
11.3 REVENUE ANALYSIS
11.4 MARKET SHARE ANALYSIS
11.5 COMPANY/BRAND COMPARATIVE ANALYSIS
11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.6.5.1 COMPANY FOOTPRINT
11.6.5.2 REGION FOOTPRINT
11.6.5.3 PRODUCT FOOTPRINT
11.6.5.4 APPLICATION FOOTPRINT
11.6.5.5 END-USER FOOTPRINT
11.7 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
11.7.1 PROGRESSIVE COMPANIES
11.7.2 RESPONSIVE COMPANIES
11.7.3 DYNAMIC COMPANIES
11.7.4 STARTING BLOCKS
11.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.7.5.1 DETAILED LIST OF KEY STARTUPS/SMES
11.7.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
11.8 COMPETITIVE SCENARIO
11.8.1 PRODUCT LAUNCHES
11.8.2 DEALS
11.8.3 OTHER DEVELOPMENTS
11.9 VALUATION AND FINANCIAL METRICS OF KEY CELL EXPANSION VENDORS

12 COMPANY PROFILES
12.2 KEY PLAYERS
12.1.1 DANAHER CORPORATION
12.1.2 THERMO FISHER SCIENTIFIC INC.
12.1.3 LONZA
12.1.4 CORNING INCORPORATED
12.1.5 MERCK KGAA
12.1.6 SARTORIUS AG
12.1.7 BD (BECTON, DICKINSON AND COMPANY)
12.1.8 BIO-TECHNE
12.1.9 GETINGE AB
12.1.10 TERUMO CORPORATION
12.1.11 FUJIFILM CORPORATION
12.1.12 EPPENDROF SE
12.1.13 MILTENYI BIOTEC
12.1.14 REPLIGEN CORPORATION
12.1.15 BIOLEGEND, INC.
12.1.16 STEMCELL TECHNOLOGIES
12.1.17 PROMOCELL GMBH
12.1.18 HIMEDIA LABORATORIES
12.2 OTHER PLAYERS
12.2.1 TAKARA BIO INC.
12.2.2 SHANGHAI DUONING BIOTECHNOLOGY CO., LTD.
12.2.3 REPROCELL INC.
12.2.4 PBS BIOTECH, INC.
12.2.5 ACROBIOSYSTEMS
11.2.6 SOLIDA BIOTECH GMBH
11.2.7 BEIJING CYTONICHE BIOTECHNOLOGY CO., LTD.
11.2.8 NEUROMICS
11.2.9 BIONET
11.2.10 CELLEXUS
Note 9: The details on business overview, financial information, products portfolio, recent developments, MarketsandMarkets view will be provided for key players. These details might not be captured in the case of unlisted companies. The provided list of players is tentative and subject to change during the research.

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS